Literature DB >> 21965348

Screening of the ryanodine 1 gene for malignant hyperthermia causative mutations by high resolution melt curve analysis.

Marcus Broman1, Kai Heinecke, Gunilla Islander, Frank Schuster, Klaus Glahn, Mikael Bodelsson, Susan Treves, Clemens Müller.   

Abstract

BACKGROUND: A diagnosis of malignant hyperthermia (MH) can be determined by performing an in vitro (muscle) contracture test (IVCT) or by identifying a known MH causative mutation in the ryanodine receptor 1 gene (RYR1). Genetic diagnosis has an advantage over IVCT because it is less invasive. Direct sequencing of the very large RYR1 coding region (15.117 bases) is a laborious and expensive task. In this study, we applied the High Resolution Melting (HRM) curve analysis as a tool to screen the entire coding region of the gene.
METHODS: Genomic DNA was extracted from peripheral blood samples in a cohort of 16 MH-susceptible patients diagnosed by the IVCT. The total coding region of RYR1 was divided and amplified by polymerase chain reaction in 131 DNA fragments and the melting profiles were compared with those of control samples. HRM curves were evaluated by Rotor-Gene Q software and visual inspection. Fragments showing aberrant melting profiles were sequenced to identify the underlying sequence variation.
RESULTS: A subset of 520 of 2520 DNA fragments (21%) showed significantly aberrant melting profiles. Upon sequencing, 131 known polymorphisms and 17 known or suspected mutations were found in 13 of 16 MH-susceptible patients (81%). Thus, the workload of sequencing was reduced by 79%.
CONCLUSION: HRM curve analysis is a sensitive and cost-effective tool for the identification of nucleotide sequence variants in complex genes such as the RYR1 gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965348     DOI: 10.1213/ANE.0b013e318228293e

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease.

Authors:  Natalia Kraeva; Elena Zvaritch; Ann E Rossi; Sanjeewa A Goonasekera; Hilal Zaid; Wanda Frodis; Alexander Kraev; Robert T Dirksen; David H Maclennan; Sheila Riazi
Journal:  Neuromuscul Disord       Date:  2012-11-24       Impact factor: 4.296

Review 2.  Personalized pediatric anesthesia and pain management: problem-based review.

Authors:  Senthil Packiasabapathy; Valluvan Rangasamy; Nicole Horn; Michele Hendrickson; Janelle Renschler; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2020-01       Impact factor: 2.533

Review 3.  Management of malignant hyperthermia: diagnosis and treatment.

Authors:  Daniel Schneiderbanger; Stephan Johannsen; Norbert Roewer; Frank Schuster
Journal:  Ther Clin Risk Manag       Date:  2014-05-14       Impact factor: 2.423

4.  Germline mutations in RYR1 are associated with foetal akinesia deformation sequence/lethal multiple pterygium syndrome.

Authors:  Arthur B McKie; Atif Alsaedi; Julie Vogt; Kyra E Stuurman; Marjan M Weiss; Hassan Shakeel; Louise Tee; Neil V Morgan; Peter G J Nikkels; Gijs van Haaften; Soo-Mi Park; Jasper J van der Smagt; Marianna Bugiani; Eamonn R Maher
Journal:  Acta Neuropathol Commun       Date:  2014-12-05       Impact factor: 7.801

5.  Rapid screening for mutations associated with malignant hyperthermia using high-resolution melting curve analysis.

Authors:  I-Min Su; Po-Kai Wang; Chun-Yu Chen; Hsien-Tse Huang; Yuan-Ji Day
Journal:  Tzu Chi Med J       Date:  2021-04-26

Review 6.  Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.

Authors:  Vladena Bauerová-Hlinková; Dominika Hajdúchová; Jacob A Bauer
Journal:  Molecules       Date:  2020-09-04       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.